Piperidine derivatives for use in the treatment or prevention of psychiatric and neurological conditions
US10562882B2 · kind B2 · utility
0Cited by
0References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 26, 2014 |
| Grant date | Feb 18, 2020 |
| Priority date | — |
| Expiry date | Jan 8, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, in which R1, R2, R3, R4 and R5 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.